DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 125 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,749,777 | +116.5% | 707,531 | +159.6% | 0.09% | +126.8% |
| Q1 2024 | $4,502,328 | +13.2% | 272,538 | 0.0% | 0.04% | -4.7% |
| Q4 2023 | $3,979,055 | +19.0% | 272,538 | 0.0% | 0.04% | +10.3% |
| Q3 2023 | $3,344,041 | +32.7% | 272,538 | +29.2% | 0.04% | +30.0% |
| Q2 2023 | $2,519,340 | +24.8% | 211,000 | +39.7% | 0.03% | +11.1% |
| Q1 2023 | $2,019,244 | -37.9% | 151,028 | 0.0% | 0.03% | -37.2% |
| Q4 2022 | $3,250,123 | +20.9% | 151,028 | +0.6% | 0.04% | +4.9% |
| Q2 2022 | $2,688,000 | – | 150,176 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |